Mark Chin, Director, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 566,404 shares at $18.30 ($10.1M) on 2019-12-09, disclosed to the SEC on 2019-12-10.
Open-market sale of $10.1M HARP by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.15 | 47,752 | $914K | 9.1% |
| 2 | $19.15 | 47,752 | $914K | 9.1% |
| 3 | $18.12 | 77,316 | $1.4M | 13.9% |
| 4 | $18.12 | 77,316 | $1.4M | 13.9% |
| 5 | $18.30 | 26,438 | $484K | 4.8% |
| 6 | $18.30 | 26,438 |
| $484K |
| 4.8% |
| 7 | $16.91 | 131,696 | $2.2M | 22.2% |
| 8 | $16.91 | 131,696 | $2.2M | 22.2% |
| Total | $17.75 avg | 566,404 | $10.1M | 100% |
| Filing → |
| IMRA | BUY | 2021-07-28 | $8.0M | — | Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-17 | $1.2M | — | Filing → |